Anti-TL1A Neutralizing Antibody
This anti-TL1A (TNF-like ligand 1A) antibody is a purified, recombinant human monoclonal antibody which recognizes the human TL1A protein. TL1A is also known as vascular endothelial growth inhibitor, VEGI and TNFSF15 (Tumor Necrosis Factor Super Family 15) .
Product Specifications
Background
TL1A is involved in immune regulation by binding to two receptors of the TNF (Tumor Necrosis Factor) family present in T and NK cells: DR3 and DcR3. Soluble TL1A induces CD4+T cell proliferation and cytokine secretion. TL1A bound to DR3 can switch immune response towards type 1 T-helper cells. Dysregulation can lead to pathologies such as inflammatory bowel disease (IBD) and other auto-immune diseases. TL1A is thus an attractive target for auto-immune disease treatment.
UniProt
O95150
Applications
Useful for studying the neutralization of TL1A in ELISA and in cellular assays.
Purification
Protein A affinity chromatography from HEK293 supernatants.
Purity
≥ 90%
Format
Aqueous buffer solution.
Shipping Conditions
-80°C
Storage Conditions
At least 6 months at -80°C.
Calculated Molecular Weight
Heavy Chain: 49 kDa + glycans; Light Chain: 23 kDa
Formulation
8 mM phosphate, pH 7.4,110 mM NaCl, 2.2 mM KCl, and 20% glycerol
Glycosylation
This antibody runs at a higher MW by SDS-PAGE due to glycosylation.
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
